Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral
about
DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stabilityThe epsin family of endocytic adaptors promotes fibrosarcoma migration and invasionBinding to DPF-motif by the POB1 EH domain is responsible for POB1-Eps15 interactionThe central proline rich region of POB1/REPS2 plays a regulatory role in epidermal growth factor receptor endocytosis by binding to 14-3-3 and SH3 domain-containing proteinsPDK1 mediates growth factor-induced Ral-GEF activation by a kinase-independent mechanismX chromosome cDNA microarray screening identifies a functional PLP2 promoter polymorphism enriched in patients with X-linked mental retardation.The Structure of the RLIP76 RhoGAP-Ral Binding Domain Dyad: Fixed Position of the Domains Leads to Dual Engagement of Small G Proteins at the MembraneSolution structure of the Eps15 homology domain of a human POB1 (partner of RalBP1)Epsins: adaptors in endocytosis?RalGEF2, a pleckstrin homology domain containing guanine nucleotide exchange factor for RalHSF-1 interacts with Ral-binding protein 1 in a stress-responsive, multiprotein complex with HSP90 in vivoCalmodulin binds RalA and RalB and is required for the thrombin-induced activation of Ral in human plateletsRegulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathwayRLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosisA-kinase anchoring protein AKAP220 binds to glycogen synthase kinase-3beta (GSK-3beta ) and mediates protein kinase A-dependent inhibition of GSK-3betaRal GTPases: crucial mediators of exocytosis and tumourigenesisRal GTPases in tumorigenesis: emerging from the shadowsTNAP and EHD1 are over-expressed in bovine brain capillary endothelial cells after the re-induction of blood-brain barrier propertiesAxil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos.Regulated RalBP1 binding to RalA and PSD-95 controls AMPA receptor endocytosis and LTDRole of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76Cbl-dependent ubiquitination is required for progression of EGF receptors into clathrin-coated pitsInteraction of POB1, a downstream molecule of small G protein Ral, with PAG2, a paxillin-binding protein, is involved in cell migration.The Eps15 homology (EH) domain.REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells.Epsin binds to the EH domain of POB1 and regulates receptor-mediated endocytosis.RLIP76 (RalBP1): The first piece of the structural puzzle.Regulation of complex formation of POB1/epsin/adaptor protein complex 2 by mitotic phosphorylation.Enhancement of endocytic uptake of HIV-1 virions into CD4-negative epithelial cells by HIV-1 gp41 via its interaction with POB1RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndrome.Rab11-FIP2, an adaptor protein connecting cellular components involved in internalization and recycling of epidermal growth factor receptors.Identification and characterization of the RLIP/RALBP1 interacting protein Xreps1 in Xenopus laevis early development.Identification of REPS2 as a putative modulator of NF-kappaB activity in prostate cancer cells.EGF signalling in prostate cancer cell lines is inhibited by a high expression level of the endocytosis protein REPS2.Ral small GTPase signaling and oncogenesis: More than just 15minutes of fameA Ral guanine exchange factor-Ral pathway is conserved in Drosophila melanogaster and sheds new light on the connectivity of the Ral, Ras, and Rap pathwaysIdentification of a human protein-derived HIV-1 fusion inhibitor targeting the gp41 fusion core structure.The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery.EH and UIM: endocytosis and more.Postgenomic global analysis of translational control induced by oncogenic signaling.
P2860
Q22010042-68B8ABFC-548E-4988-91CA-C1969415F5C1Q24295295-A327055A-4014-4F49-92EB-CB7A41869B69Q24304396-C8708724-6A57-49B0-92CD-3BA92D23A895Q24316124-279D99F9-868A-4892-9589-620AA6E99DFDQ24536252-D2AEB8F4-8AC5-4EB3-AD68-9A3D2C57E82CQ24681478-91165358-2D84-4D88-8793-53206DBF08BEQ27680559-EFDD4087-C0B3-485E-964B-E449718A9E56Q27766856-6BD27D51-94B8-485E-AAA8-5D9ED385DE1FQ27939888-172C5DD6-0E2E-4910-98D2-24DC3F43308AQ28140465-0599140B-EACA-4E23-ADB1-71926C694FF2Q28181223-175735C9-6BFD-446A-8F93-C7FFDDEE94F7Q28201129-8965DBD8-802E-46C8-A512-A768B80F20C6Q28205522-1762E3A4-1A3A-4487-B0CD-4393F91D0491Q28207629-728C127A-0579-42A4-B718-58452692317CQ28216363-F3B35266-C190-4B4A-A2B6-73CC8CD50B5BQ28259292-B81DC19C-FCCE-4D76-9DC9-ADF14C79BCE9Q28294053-10F82937-F256-4328-82AC-796B535AA765Q28484667-094563C8-804D-494B-938C-B3BF1FE67145Q28567628-B8545D1B-881E-44EF-A9AD-CD8F2501A6C9Q28582590-93F356A3-F26C-4CEF-B9C4-727CF5BADFA6Q30051796-266D8AFE-3F17-43F3-8AA9-628C51B2997BQ30164018-CAADB5F6-34E7-4446-92B9-497232331A2FQ30165274-40AC83B2-363D-4F77-BC7D-E3261A6FB647Q30827834-2AA501E8-8C4D-478B-BD83-975D691C6EB8Q30938786-DC24FCA5-2F39-47BC-900B-7C83D73A3396Q33292368-2FC55D7C-23BC-4472-8C00-D36C2C4516F8Q33351604-6FEE2F2E-F87D-48D6-8069-ABD9DA3CB3B8Q33898116-DDB08A40-77F6-4785-BB0E-E11148E36CB3Q33920132-0E2A41D1-6C0A-4601-9E0D-F35A6D892B8BQ34023922-0A2A776B-283E-49FB-BD2B-B945164DF4E6Q34153006-1D23A771-82FF-43FD-AE2E-E2E2547CDE75Q34193705-82260A7E-B20A-4159-A5E1-2BA0B0EC2583Q34325532-B233F484-FE15-4E4A-BC30-CF07F2809A10Q34354134-48B182C3-9C2F-4319-936E-33C843259891Q34363605-FBA6E094-FB61-4186-AC67-0BFEF76C838CQ34463200-E016E026-0946-4055-A77B-3D09A3F77C70Q34761552-90E1C040-81B9-4C10-93B5-958E9E0846EEQ35083727-09EFC7A9-33B0-480B-8C6E-E7C855136E02Q35609314-9A52E5B3-FBDA-4A53-A675-41E0900D5457Q35750140-30A962C3-5803-4388-9033-743BA326173F
P2860
Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Identification and characteriz ...... tative effector protein of Ral
@ast
Identification and characteriz ...... tative effector protein of Ral
@en
Identification and characteriz ...... tative effector protein of Ral
@en-gb
Identification and characteriz ...... tative effector protein of Ral
@nl
type
label
Identification and characteriz ...... tative effector protein of Ral
@ast
Identification and characteriz ...... tative effector protein of Ral
@en
Identification and characteriz ...... tative effector protein of Ral
@en-gb
Identification and characteriz ...... tative effector protein of Ral
@nl
prefLabel
Identification and characteriz ...... tative effector protein of Ral
@ast
Identification and characteriz ...... tative effector protein of Ral
@en
Identification and characteriz ...... tative effector protein of Ral
@en-gb
Identification and characteriz ...... tative effector protein of Ral
@nl
P2093
P2860
P3181
P356
P1476
Identification and characteriz ...... tative effector protein of Ral
@en
P2093
P2860
P304
P3181
P356
10.1074/JBC.273.2.814
P407
P577
1998-01-09T00:00:00Z